Royalty Pharma (RPRX) market cap

Market cap today
$39.49B

Royalty Pharma (RPRX) has a market cap of $39.49B. At the end of fiscal 2025 (December 31, 2025) its market cap was $21.81B. That is 43.9% higher than the $15.15B of fiscal 2024. Today's figure is 81.1% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 09:08 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$39.49B
Market cap, fiscal 2025
$21.81B
Change on fiscal 2024
+43.9%
Growth, 5 years
+3.0% a year
Highest on record
$21.81Bfiscal 2025
Lowest on record
$15.15Bfiscal 2024
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Royalty Pharma market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 3.0% a year. Across the 6 fiscal year-ends on record (2020–2025), the highest was $21.81B in fiscal 2025 and the lowest $15.15B in fiscal 2024.

History · 6 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Royalty Pharma market cap, year by year

Royalty Pharma (RPRX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$39.49B—$68.68—
2025$21.81B 43.9% up$38.64564.46M
2024$15.15B 10.5% down$25.51594.00M
2023$16.94B 2.2% down$28.09602.90M
2022$17.31B 4.7% up$39.52437.97M
2021$16.53B 12.0% down$39.85414.80M
2020$18.79B—$50.05375.46M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on RPRX

Royalty Pharma, figure by figure

Royalty Pharma (RPRX) overview: price, valuation and scorecardAll health care companies by market value

Royalty Pharma market cap: questions and answers

What is Royalty Pharma's market cap?

Royalty Pharma (RPRX) has a market cap of $39.49B. At the end of fiscal 2025 (December 31, 2025) its market cap was $21.81B. That is 43.9% higher than the $15.15B of fiscal 2024.

What is the growth rate of Royalty Pharma's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 3.0% a year.

What are the highest and lowest market cap figures on record for Royalty Pharma?

Across the 6 fiscal year-ends on record (2020–2025), the highest was $21.81B in fiscal 2025 and the lowest $15.15B in fiscal 2024.

How is Royalty Pharma's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Royalty Pharma it is on record here for 6 fiscal years, 2020 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Royalty Pharma (RPRX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/RPRX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.